Malignant transformation by ras and other oncogenes produces common alterations in inositol phospholipid signaling pathways
about
Lithium administration to preadolescent rats causes long-lasting increases in anxiety-like behavior and has molecular consequences.Persistent induction of cyclooxygenase in p60v-src-transformed 3T3 fibroblasts.Platelet-derived growth factor stimulates formation of active p21ras.GTP complex in Swiss mouse 3T3 cells.Glucocorticoid and cAMP induction mechanisms are differentially affected by the p85gag-mos oncoprotein.Accumulation of p21ras.GTP in response to stimulation with epidermal growth factor and oncogene products with tyrosine kinase activityIncreased conversion of phosphatidylinositol to phosphatidylinositol phosphate in Dictyostelium cells expressing a mutated ras gene.Alteration of the lipid profile in lymphomas induced by MYC overexpression.Early regulation of membrane excitability by ras oncogene proteinsFatty acid oxidation and signaling in apoptosis.Reorganization of actin cytoskeleton by the phosphoinositide metabolite glycerophosphoinositol 4-phosphatePlatelet-derived growth factor stimulation of GTPase-activating protein tyrosine phosphorylation in control and c-H-ras-expressing NIH 3T3 cells correlates with p21ras activationAlterations of G-protein coupling function in phosphoinositide signaling pathways of cells transformed by ras and other membrane-associated and cytoplasmic oncogenes.Induction of differentiation in v-Ha-ras-transformed MDCK cells by prostaglandin E2 and 8-bromo-cyclic AMP is associated with a decrease in steady-state level of inositol 1,4,5-trisphosphateAntisense-fos RNA causes partial reversion of the transformed phenotypes induced by the c-Ha-ras oncogene.Oncogene N-ras mediates selective inhibition of c-fos induction by nerve growth factor and basic fibroblast growth factor in a PC12 cell lineModulation of arachidonic acid metabolism by Rous sarcoma virus.Fast receptor-induced formation of glycerophosphoinositol-4-phosphate, a putative novel intracellular messenger in the Ras pathway.The biochemistry of ras p21.Ambient ionization mass spectrometric analysis of human surgical specimens to distinguish renal cell carcinoma from healthy renal tissue.Loss of responsiveness of an AP1-related factor, PEBP1, to 12-O-tetradecanoylphorbol-13-acetate after transformation of NIH 3T3 cells by the Ha-ras oncogene.Molecular characterization of a glycerophosphoinositol transporter in mammalian cells.Comparison of the levels of inositol metabolites in transformed haemopoietic cells and their normal counterparts.Mitogenic signal transduction in normal and transformed 32D hematopoietic cells.A Ca2(+)-activated K+ current in ras-transformed fibroblasts is absent from nontransformed cells.NIH-3T3 cells transformed with a ras oncogene exhibit a protein kinase C-mediated inhibition of agonist-stimulated Ca2+ inflow.Scrape-loaded p21ras down-regulates agonist-stimulated inositol phosphate production by a mechanism involving protein kinase C.Regulation of Na+-H+ exchange in normal NIH-3T3 cells and in NIH-3T3 cells expressing the ras oncogene.Overexpression of phosphatidylinositol transfer protein alpha in NIH3T3 cells activates a phospholipase A.On the reaction kinetics of the radioadaptive response in cultured mouse cells.
P2860
Q30427997-1D70A8A9-CF0F-47AB-A898-D5CE211BF543Q33559772-82B317AB-64F5-4D7A-A3AC-AC48370097C8Q33731289-BB5458A1-69AC-40B6-AB7B-5C87700544A7Q33832026-4AF2A98A-C144-4526-96BD-582A0A600CD5Q33840225-6F9A2160-B3B6-4844-AC9C-68D205E5C7ACQ33909605-4CD3EF91-4B96-4EC8-8A85-5E8863CF81DCQ33971890-6C941E1C-5BC3-4535-9197-FA2649F5C6CFQ34126476-BF41E5B3-6D36-4D03-8144-41699BDD22ACQ34658888-059A7ADB-72E2-4ADB-A1D0-0B0002C85888Q34764253-AE76090C-3DE8-4450-AD88-74BA7DD7F629Q36699705-A8DB7DBB-FAF4-48E9-BF40-43C4E4CAC9A4Q36711701-03AD170E-2157-40C6-A702-E55A2E91B643Q36713007-1A26A6AE-BCF6-46EA-B71E-EABAF275B1A0Q36755501-052A3FE4-D4F6-4697-804A-0714F47EF07DQ36755516-E6034298-6B3D-40A3-8E49-F0EF1303F749Q36829235-70CA4855-8159-4819-91FE-AB5086F2A851Q37385125-A0BE9506-885F-4F36-87B8-995B26872809Q37523399-A9850754-AF1D-4A86-8EC9-9EF6C85CDC08Q38864602-20443F10-D300-4848-A1E0-65F14DCAD9A5Q40116700-84E60D3F-E5EC-4646-B3AE-1E14AFEE9B64Q40201918-9C74D6D4-280F-4BC6-A270-40BC14274596Q41575461-9DBE644E-4B64-4B0F-AF68-84771D2872C4Q41660466-EBAA64C4-C08A-4EA6-8B3A-CF8BF6CCE5E0Q41707008-5BA1FF88-7BA8-49A3-A9B7-CCF3098813D8Q41718147-FF3E1999-D736-449D-A235-6ACA399ACF43Q42798310-BA303C55-B030-4260-8198-38B1D24B6D64Q42799221-F0EF6D75-F953-4C48-A1E4-A53BB89DBE25Q42808035-B079B1EB-A88B-4377-9D2F-088DE2E12881Q53461672-719CCE35-65B0-45F0-950E-B5A6412B7742
P2860
Malignant transformation by ras and other oncogenes produces common alterations in inositol phospholipid signaling pathways
description
1988 nî lūn-bûn
@nan
1988 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
1988 թվականի հունիսին հրատարակված գիտական հոդված
@hy
1988年の論文
@ja
1988年論文
@yue
1988年論文
@zh-hant
1988年論文
@zh-hk
1988年論文
@zh-mo
1988年論文
@zh-tw
1988年论文
@wuu
name
Malignant transformation by ra ...... hospholipid signaling pathways
@ast
Malignant transformation by ra ...... hospholipid signaling pathways
@en
Malignant transformation by ra ...... ospholipid signaling pathways.
@nl
type
label
Malignant transformation by ra ...... hospholipid signaling pathways
@ast
Malignant transformation by ra ...... hospholipid signaling pathways
@en
Malignant transformation by ra ...... ospholipid signaling pathways.
@nl
prefLabel
Malignant transformation by ra ...... hospholipid signaling pathways
@ast
Malignant transformation by ra ...... hospholipid signaling pathways
@en
Malignant transformation by ra ...... ospholipid signaling pathways.
@nl
P2093
P2860
P356
P1476
Malignant transformation by ra ...... hospholipid signaling pathways
@en
P2093
P2860
P304
P356
10.1073/PNAS.85.12.4271
P407
P577
1988-06-01T00:00:00Z